Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
2016 · Annals of Surgical Oncology · 295 citations
https://doi.org/10.1245/s10434-016-5286-0
E
Eddy C. Hsueh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
8.7K
Citations
45
h-index
77
i10-index
Eddy C. Hsueh is an academic researcher from Saint Louis University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cutaneous Melanoma Detection and Management & Melanoma and MAPK Pathways. The author has an h-index of 45, co-authored 137 publications.
ORCID: 0000-0002-0327-2605Papers by this author
worksUtility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
2017 · Biomarker Research · 172 citations
https://doi.org/10.1186/s40364-017-0093-8
Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies
2013 · Experimental Hematology and Oncology · 105 citations
https://doi.org/10.1186/2162-3619-2-31
SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex
2018 · Molecular Cancer · 80 citations
https://doi.org/10.1186/s12943-018-0824-y
Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test
2017 · Journal of Hematology & Oncology · 79 citations
https://doi.org/10.1186/s13045-017-0520-1
Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma
2019 · Cancer Medicine · 73 citations
https://doi.org/10.1002/cam4.2128
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat